Company intelligence / Profile preview

Genome Express

Grenoble, France

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Genome Express was a prominent French biotechnology service company focused on genomics and molecular biology. Established in 1993, the company provided a wide range of services including high-throughput DNA sequencing, genotyping, and gene expression analysis to the pharmaceutical and academic sectors. It operated several facilities across France and was recognized as a leader in the European genomics market. In 2006, the company was acquired by Cogenics, the genomics division of Clinical Data, Inc., and its operations were eventually integrated into Eurofins Genomics following subsequent transactions.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Genome Express.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genome Express.

Explore the full profile